Stock ALOPM ONCODESIGN PRECISION MEDICINE
Add to a list
To use this feature you must be a member
Log inSign up

Company Oncodesign Precision Medicine

Equities

ALOPM

FR001400CM63

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 06:51:03 21/06/2024 pm IST 		5-day change 1st Jan Change
1.05 EUR 0.00% Intraday chart for Oncodesign Precision Medicine -4.55% -41.99%
15/05 Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents CI
25/01 Oncodesign Precision Medicine: fundraising on the horizon CF

Business Summary

Oncodesign Precision Medicine specializes in the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology. The company aims to discover new targeted therapy molecules for cancers without current solutions, including therapy-resistant and metastatic cancers.

Number of employees: 19

Sales per Business

EUR in Million2022Weight2023Weight Delta
Precision Medicine
100.0 %
8 100.0 % 1 100.0 % -86.57%

Sales per region

EUR in Million2022Weight2023Weight Delta
France
100.0 %
8 100.0 % 1 100.0 % -86.57%

Managers

Managers TitleAgeSince
Philippe Genne CEO
 Chief Executive Officer 62 31/22/31
Jan Hoflack BRD
 Director/Board Member 63 14/22/14
Karine Lignel BRD
 Director/Board Member 55 14/22/14

Members of the board

Members of the board TitleAgeSince
Kamel Besseghir BRD
 Director/Board Member 75 14/22/14
Philippe Genne CEO
 Chief Executive Officer 62 31/22/31
Karine Lignel BRD
 Director/Board Member 55 14/22/14
Jan Hoflack BRD
 Director/Board Member 63 14/22/14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,679,514 14,738,086 ( 88.36 %) 44,588 ( 0.2673 %) 88.36 %

Shareholders

NameEquities%Valuation
OFI Invest Asset Management SA
0.8688 %
158,037 0.8688 % 212 740 €
Claresco Finance SA
0.3727 %
67,795 0.3727 % 91 262 €
Friedland Gestion SAS
0.1910 %
34,741 0.1910 % 46 766 €
Gestys SA
0.0770 %
14,000 0.0770 % 18 846 €

Company contact information

Oncodesign Precision Medicine SA

18 rue Jean Mazen

21000, Dijon

+33 310 451 820

address Oncodesign Precision Medicine(ALOPM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Ratings for Oncodesign Precision Medicine

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.05 EUR
Average target price
2.48 EUR
Spread / Average Target
+136.19%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ONCODESIGN PRECISION MEDICINE Stock Oncodesign Precision Medicine
-41.99% 2.04Cr
MODERNA, INC. Stock Moderna, Inc.
+34.14% 5.15TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-6.54% 3.9TCr
LONZA GROUP AG Stock Lonza Group AG
+34.92% 3.89TCr
CELLTRION, INC. Stock Celltrion, Inc.
-12.11% 2.67TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.62% 2.61TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-13.43% 1.99TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+43.73% 1.37TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.81% 1.24TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.54% 1.17TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALOPM Stock
  4. Company Oncodesign Precision Medicine